IP Cell - Indian Pharmaceutical Alliance
In January 2009, the IPA was gravely concerned about the frequent reports relating to the process of examination and quality of patents in India. It also realized the consequences of inaction, as it would create jurisprudence which, in the long run, could seriously hurt the National Companies and public health.